Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive intra-arterial tenecteplase after successful thrombectomy in large vessel occlusion stroke
ChiCTR2200064809Phase 3Completed
- Sponsor
- The 2nd Affiliated Hospital of Chongqing Medical University
- Start
- Oct 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of tenecteplase in ischemic stroke and Large-Vessel Ischemic Stroke (LVO) (2 arms), sponsored by The 2nd Affiliated Hospital of Chongqing Medical University. Started Oct 2022; status: completed.
02
Drugs
tenecteplase
03
Conditions
ischemic strokeLarge-Vessel Ischemic Stroke (LVO)
Beyond the preview
Go deeper on ChiCTR2200064809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200064809.